The behavioural effects of pramipexole, a novel dopamine receptor agonist

By Maj J.   Rogoz Z.   Skuza G.   Kolodziejczyk K.  

European Journal of Pharmacology, Vol. 324, Iss. 1, 1997-04 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

Inhibition of dopamine neuron firing by pramipexole, a dopamine D 3 receptor-preferring agonist: comparison to other dopamine receptor agonists

By Piercey M.F.   Hoffmann W.E.   Smith M.W.   Hyslop D.K.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 35-44

Elsevier

Access to resources Recommend Favorite

Effects of the D 3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats

By Lagos P.   Scorza C.   Monti J.M.   Jantos H.   Reyes-Parada M.   Silveira R.   Ponzoni A.  

European Neuropsychopharmacology, Vol. 8, Iss. 2, 1998-05 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite

The locomotor effects of a putative dopamine D 3 receptor agonist in developing rats

By Frantz K.   Babcock D.   Van Hartesveldt C.  

European Journal of Pharmacology, Vol. 302, Iss. 1, 1996-04 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

The very-high-efficacy 5-HT 1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury

By Wu W.-P.   Hao J.-X.   Xu X.-J.   Wiesenfeld-Hallin Z.   Koek W.   Colpaert F.C.  

European Journal of Pharmacology, Vol. 478, Iss. 2, 2003-10 ,pp. : 131-137

Elsevier

Access to resources Recommend Favorite